Literature DB >> 20549422

Levamisole-induced occlusive necrotizing vasculitis of the ears after use of cocaine contaminated with levamisole.

Jennie A Buchanan1, Jody A Vogel, Aaron M Eberhardt.   

Abstract

Based on the best available data, approximately 2.1 million Americans use illicit cocaine each month; for the last several months, 30% of that cocaine has been "cut" with a veterinary pharmaceutical, levamisole. Levamisole can cause agranulocytosis, leaving patients susceptible to fulminate and opportunistic infections and also can cause a debilitating cutaneous necrotizing vasculitis. In this manuscript, we describe a case and provide an image of levamisole-induced necrotizing vasculitis of the ears. © American College of Medical Toxicology 2010

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20549422      PMCID: PMC3614109          DOI: 10.1007/s13181-010-0097-3

Source DB:  PubMed          Journal:  J Med Toxicol        ISSN: 1556-9039


  2 in total

1.  Purpura of the ears: a distinctive vasculopathy with circulating autoantibodies complicating long-term treatment with levamisole in children.

Authors:  F Rongioletti; L Ghio; F Ginevri; D Bleidl; S Rinaldi; A Edefonti; C Gambini; G Rizzoni; A Rebora
Journal:  Br J Dermatol       Date:  1999-05       Impact factor: 9.302

2.  Ear lobe bilateral necrosis by levamisole-induced occlusive vasculitis in a pediatric patient.

Authors:  S Menni; G Pistritto; R Gianotti; L Ghio; A Edefonti
Journal:  Pediatr Dermatol       Date:  1997 Nov-Dec       Impact factor: 1.588

  2 in total
  11 in total

Review 1.  Lupus anticoagulant and ANCA associated thrombotic vasculopathy due to cocaine contaminated with levamisole: a case report and review of the literature.

Authors:  Shuchi Gulati; Anthony A Donato
Journal:  J Thromb Thrombolysis       Date:  2012-07       Impact factor: 2.300

Review 2.  Cutaneous vasculopathy associated with levamisole-adulterated cocaine.

Authors:  Huy Tran; Debbie Tan; Thomas P Marnejon
Journal:  Clin Med Res       Date:  2012-06-21

3.  Reversible retiform purpura: a sign of cocaine use.

Authors:  Christina Han; Gayatri Sreenivasan; Jan P Dutz
Journal:  CMAJ       Date:  2011-03-14       Impact factor: 8.262

4.  A novel cutaneous vasculitis syndrome induced by levamisole-contaminated cocaine.

Authors:  Rachel L Gross; Jason Brucker; Asena Bahce-Altuntas; Maria A Abadi; Jules Lipoff; David Kotlyar; Peter Barland; Chaim Putterman
Journal:  Clin Rheumatol       Date:  2011-06-25       Impact factor: 2.980

5.  Contaminated cocaine and antineutrophil cytoplasmic antibody-associated disease.

Authors:  Martina M McGrath; Tamara Isakova; Helmut G Rennke; Ann M Mottola; Karen A Laliberte; John L Niles
Journal:  Clin J Am Soc Nephrol       Date:  2011-10-06       Impact factor: 8.237

6.  Levamisole-induced occlusive necrotising vasculitis in cocaine abusers: an unusual cause of skin necrosis and neutropenia.

Authors:  Cassius D Belfonte; Victoria K Shanmugam; Nicole Kieffer; Shodeinde Coker; Suelyn Boucree; Gail Kerr
Journal:  Int Wound J       Date:  2012-06-21       Impact factor: 3.315

7.  Levamisole/Cocaine Induced Systemic Vasculitis and Immune Complex Glomerulonephritis.

Authors:  Lohit Garg; Sagar Gupta; Abhishek Swami; Ping Zhang
Journal:  Case Rep Nephrol       Date:  2015-07-28

8.  Levamisole-adulterated cocaine induced skin necrosis of nose, ears, and extremities: Case report.

Authors:  Lauren A Lawrence; Jose L Jiron; Ho-Sheng Lin; Adam J Folbe
Journal:  Allergy Rhinol (Providence)       Date:  2014-01

9.  Levamisole-induced leukocytoclastic vasculitis and neutropenia in a patient with cocaine use: an extensive case with necrosis of skin, soft tissue, and cartilage.

Authors:  Natasha Purai Arora; Tania Jain; Ravinder Bhanot; Suganthini Krishnan Natesan
Journal:  Addict Sci Clin Pract       Date:  2012-09-24

10.  Cocaine induced vasculitis: have we found a culprit?

Authors:  Alfredo Sánchez-Cruz; Sylmarie Marrero; José Betancourt; Myrna Andino; Adolfo Lopez; Jose Gutierrez-Nuñez
Journal:  Case Rep Rheumatol       Date:  2012-12-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.